Page 42

Journal_de_Pharmacie_de_Belgique_n3_ septembre_2015

Journal de Pharmacie de Belgique - 97ème a 42 nnée n° 3 - septembre 2015 18 Hecq JD, Vandenbroucke J, Lefebure MA et al. Centralized intravenous additives service (CIVA). Implementation manual for Belgian Hospital Pharmacist. BVZA-ABPH; 1999. 19 Berthouzoz S, Berger L, Bonnabry P, Pannatier A. The hospital pharmacist: an important contributor to improved patient safety in the hospital. Chimia (Aarau). 2012; 66(5) : 300-3. 20 Hennebicq S, Secretan P.-H, Carrez L, Hecq JD. Présentation d’une démarche d’aide et de réflexion pour la mise en place de doses standards appliquées aux préparations et reconstitution d’injectables en milieu hospitalier. Journal de Pharmacie de Belgique 2014; 96 : 42-54. 21 Bing CM. Extended stability of parenteral drugs 2001, ASHP, Bethesda, MD. 22 Catania PN. King Guide to parenteral Admixtures, 2014. King Guide Publications. Napa, California. 23 Hecq JD. Stabilité des médicaments injectables en perfusion. 33 ans de recherche bibliographique. ABPHBVZA, Brussels. Edition 2015. 24 Morris N. Australian Handbook injectable drugs. 1997, 2nd edition. SHPA. 25 Trissel LA. Handbook on injectable drugs. 2013, ASHP, Bethesda, MD. 26 Vigneron J, Gindre I, Daouphars M, Demoré B, Montfort P, Georget S, Chenot E, Noirez V, Commun N, Laureli F, Perrin A, Lux M, Hoffman MA, Hoffman M. Stabilis 3 ; www.stabillis.org. 10 Hecq JD, Evrard JM, Gillet P, Gilain M., Crucifix MB, Gardin Cl, Lecoq MC, Watterman Y. Standardisation de la procédure de dilution et d’administration des antiinfectieux intraveineux utilisés aux Cliniques Universitaires U.C.L. de Mont- Godinne. Pharmakon 1998; 114 : 72-80. 11 Nemec K, Kopelent-Frank H, Greif R. Standardisation of infusion solutions to reduce the risk of incompatibility. Am J Health-Syst Pharm 2008; 65(17) : 1648-1654. 12 Phillips MS. Standardizing i.v. infusion concentrations : national survey results. Am J Health-Syst Pharm 2011; 68 (22) : 2176-2182. 13 Gaspar Carreño M, Torrico Martín F, Novajarque Sala L, Batista Cruz M, Ribeiro Gonçalves P, Porta Oltra B, Sánchez Santos JC. Parenteral administration medicines: recommendations of preparation, administration and stability. Farm Hosp 2014; 38(6) : 461-7. 14 Hecq JD. Centralized Intravenous Additive Services (CIVAS): The state of the art in 2010. Annales Pharmaceutiques Françaises 2011; 69 : 30-37. 15 Hecq JD. Ten Years of European hospital pharmacy history: centralized intravenous additives services. Eur J Hosp Pharm 2004 ; 10(6) : 47. 16 Cousins DH. Centralized intravenous additives services. Implementation manual. Baxter Healthcare Ltd, 1990. 17 Needle R, Sizer T. The CIVAS handbook. Cambridge, UK: Pharmaceutical Press; 1998. Références 1 Turco SJ. Parenteral admixtures and incompatibilities. Sterile dosage forms. Their preparation and clinical application. Lea & Febiger, 4th edition, Philadelphia, 1994; 239. 2 Simmons BP. CDC Guidelines for the prevention and control of nosocomial infections, Guideline for prevention of intravascular infections. Am J Infect Control 1983; 11 : 183-199. 3 Takis K, Barber N. Ethnographic study of incidence and severity of intravenous drug errors. Br Med J 2003; 326 : 684-690. 4 Westbrook JI, Rob MI, Woods A, Parry D. Errors in the administration of intravenous medications in hospital and the role of correct procedures and nurse experience. BMJ Qual Saf 2011; 20 : 2027-2034. 5 Ong WM, Subasyini S. Medications errors in intravenous drug preparation and administration. Med J Malaysia 2013; 68 : 52-57. 6 Vijayakumar A, Sharon EV, Teena J, Nobil S, Nazeer I. A clinical study on drug related problems associated with intravenous drug administration. J Basic Clin Pharmacy 2014; 5 : 49-53. 7 Valentin A, Capuzzo M, Guidet B, Moreno R, Metnitz B, Bauer P, Metnitz P. Errors in administration of parenteral drugs in intensive care units : multinational prospective study. BMJ 2009; 12(338) : b814. 8 Rwabihama JP, Aubourg R, Oliary J et al. Usage et mésusage de la voie intraveineuse pour l’administration de médicaments en médecine interne. Presse Médicale; 2006 ; 35 : 1453-1460. 9 Clarck C. Safety with injectable medecines. Clin Pharm Eur 2007; 7 : 13-16. étude Farmaceutisch Tijdschrift voor België


Journal_de_Pharmacie_de_Belgique_n3_ septembre_2015
To see the actual publication please follow the link above